Research ArticleClinical Investigations
124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET
Joseph A. O'Donoghue, Peter M. Smith-Jones, John L. Humm, Shutian Ruan, Daniel A. Pryma, Achim A. Jungbluth, Chaitanya R. Divgi, Jorge A. Carrasquillo, Neeta Pandit-Taskar, Yuman Fong, Vivian E. Strong, Nancy E. Kemeny, Lloyd J. Old and Steven M. Larson
Journal of Nuclear Medicine December 2011, 52 (12) 1878-1885; DOI: https://doi.org/10.2967/jnumed.111.095596
Joseph A. O'Donoghue
Peter M. Smith-Jones
John L. Humm
Shutian Ruan
Daniel A. Pryma
Achim A. Jungbluth
Chaitanya R. Divgi
Jorge A. Carrasquillo
Neeta Pandit-Taskar
Yuman Fong
Vivian E. Strong
Nancy E. Kemeny
Lloyd J. Old
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 52, Issue 12
December 1, 2011
124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET
Joseph A. O'Donoghue, Peter M. Smith-Jones, John L. Humm, Shutian Ruan, Daniel A. Pryma, Achim A. Jungbluth, Chaitanya R. Divgi, Jorge A. Carrasquillo, Neeta Pandit-Taskar, Yuman Fong, Vivian E. Strong, Nancy E. Kemeny, Lloyd J. Old, Steven M. Larson
Journal of Nuclear Medicine Dec 2011, 52 (12) 1878-1885; DOI: 10.2967/jnumed.111.095596
124I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET
Joseph A. O'Donoghue, Peter M. Smith-Jones, John L. Humm, Shutian Ruan, Daniel A. Pryma, Achim A. Jungbluth, Chaitanya R. Divgi, Jorge A. Carrasquillo, Neeta Pandit-Taskar, Yuman Fong, Vivian E. Strong, Nancy E. Kemeny, Lloyd J. Old, Steven M. Larson
Journal of Nuclear Medicine Dec 2011, 52 (12) 1878-1885; DOI: 10.2967/jnumed.111.095596
Jump to section
Related Articles
Cited By...
- The structure of the humanised A33 Fab C226S variant, an immunotherapy candidate for colorectal cancer
- Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis
- Proceedings: Pathways for Successful Translation of New Imaging Agents and Modalities--Phase III Studies
- Development of 124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
- Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET
- Phase II Study of Lutetium-177-Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer
- Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study
- Advances in Immuno-Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology